Pfizer, BioNTech's Combined Flu-Covid-19 Shot Misses Late-Stage Study Goal
Pfizer, BioNTech's Combined Flu-Covid-19 Shot Misses Late-Stage Study Goal
辉瑞和biontech合成的流感新冠疫苗未达到后期研究目标
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册